Migraines are often linked to increased activity of calcitonin gene-related peptide (CGRP), a signaling molecule known to trigger pain sensitivity, light sensitivity, and other migraine symptoms. In this preclinical study, researchers examined whether a combination of cannabidiol (CBD) and tetrahydrocannabinol (THC) could reduce migraine-like symptoms caused by central CGRP administration in mice. Scientists used established […]
Research-Based Information
Cannabidiol (CBD) Improves Cognitive Recovery After Traumatic Brain Injury in Preclinical Study (pub. Jan 2026)
Traumatic brain injury (TBI) can lead to long-term cognitive problems caused by oxidative stress, inflammation, and neuronal cell death following the initial injury. In this study, researchers investigated whether cannabidiol (CBD), a non-intoxicating compound from hemp, could improve cognitive impairment after TBI. Using both cell-based experiments and animal models of brain injury, scientists evaluated memory […]
Cannabis sativa Extract Shows Early Anticancer Activity Against Human Breast Cancer Cells (pub. Dec 2025)
Breast cancer remains one of the most common cancers worldwide, prompting researchers to investigate new plant-based compounds that may influence tumor growth. In this laboratory study, scientists examined a dichloromethane extract from Cannabis sativa to understand how its natural phytochemicals affect human breast cancer cell lines (MDA-MB-231 and MCF-7). The research focused on whether compounds […]